Andrew Serafin - CHIEF STRATEGY OFFICER at Harmony Biosciences Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Strategy Officer
Issuer Symbol
HRMY on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Serafin since 07 Mar 2025

Holdings reported by Andrew Serafin for Harmony Biosciences Holdings, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 7,800 $417,361 $40.13 25 Jan 2026 Direct Common Stock
Common Stock 1,474 $54,272 $36.82 25 Jan 2026 Direct
Stock Option 42,600 22 Jan 2026 Direct Common Stock

Transactions reported by Andrew Serafin for Harmony Biosciences Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.